1
Jacob Berger, Lee Allen Flippin, John Cureton Hunter, David Garrett Loughhead, Robert James Weikert: Treatment of neuropathic pain. Syntex, Brian Lewis, Janet K Kaku, November 18, 1997: US05688830 (18 worldwide citation)

This invention relates to a compound of the Formula I: ##STR1## as a racemic mixture and its individual enantiomers, in particular the (R)-enantiomer, and their pharmaceutically acceptable salts. These compounds are useful as sodium channel blockers, and are particularly useful for the alleviation o ...


2
Ann Marie Madera, Robert James Weikert: 2,7-substituted indoles. Roche Palo Alto, Robert C Hall, July 24, 2007: US07247651 (8 worldwide citation)

The present invention provides a compound of the formula: a pharmaceutically acceptable salt or a prodrug thereof, where R1, R2, R3, R4, and n are those defined herein. The present invention also provides compositions comprising, methods for using, and methods for preparing Compound of Formula I.


3
David Garrett Loughhead, Xiao Fa Lin, Robert James Weikert, Lee Allen Flippin: Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain. Syntex USA, Rohan Peries, Janet Kaku, August 29, 2000: US06110937 (7 worldwide citation)

Compounds selected from the group of compounds represented by Formula I: ##STR1## as an individual isomer or as a racemic or non-racemic mixture of isomers, and their pharmaceutically acceptable salts and N-oxides thereof; are sodium channel blockers, and thus exhibit useful pharmacological properti ...


4

5
Ann Marie Madera, Robert James Weikert: Amino-tetralin derivatives as muscarinic receptor antagonists. Syntex, Rohan Peries, Brian Buckwalter, October 21, 2003: US06635658 (5 worldwide citation)

This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I:


6
Ryan Craig Schoenfeld, Robert James Weikert: Benzazepine derivatives and uses thereof. Roche Palo Alto, Robert C Hall, November 24, 2009: US07622462 (5 worldwide citation)

Compounds of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ar, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, methods of preparing the compounds, and method of using the compounds for treatment of monoamine reuptake inhibitor-m ...


7
Sharada Shenvi Labadie, Clara Jeou Jen Lin, Francisco Xavier Talamas, Robert James Weikert: Heterocyclic antiviral compounds. Roche Palo Alto, Brian L Buckwalter, December 6, 2011: US08071797 (4 worldwide citation)

Compounds having the formula I wherein R1, R2, R3, R4, R5 and X are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.


8
Ann Marie Madera, Robert James Weikert: Amino-tetralin derivatives as muscarinic receptor antagonists. Syntex, Brian L Buckwalter, October 19, 2004: US06806278 (2 worldwide citation)

This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I:


9
Christine E Brotherton Pleiss, Ann Marie Madera, Robert James Weikert: 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists. Syntex, Brian Buckwalter Rohan Peries, September 30, 2003: US06627644 (2 worldwide citation)

This invention relates to compounds which are generally muscarinic receptor antagonists and which are represented by Formula I:


10
Robert James Weikert, Ann Marie Madera, Russell Stephen Stabler: Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists. Syntex, Brian Buckwalter, November 11, 2003: US06645958 (2 worldwide citation)

This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I: